Man Group PLC Abb Vie Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Man Group PLC holds 821,327 shares of ABBV stock, worth $150 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

821,327

Previous 882,964 6.98%

Holding current value

$150 Million

Previous $151 Million 7.1%

% of portfolio

0.45%

Previous 0.4%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $10.1 Million - $12.3 Million	-61,637 Reduced 6.98%	821,327 $162 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $56.9 Million - $66.4 Million	-367,300 Reduced 29.38%	882,964 $151 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.68 Million - $1.91 Million	10,515 Added 0.85%	1,250,264 $228 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $7.55 Million - $8.5 Million	-54,851 Reduced 4.24%	1,239,749 $192 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $56.3 Million - $65.2 Million	421,779 Added 48.32%	1,294,600 $193 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $59.5 Million - $74.1 Million	449,217 Added 106.05%	872,821 $118 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $8.25 Million - $9.5 Million	-57,068 Reduced 11.87%	423,604 $67.5 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $31.4 Million - $37.7 Million	227,138 Added 89.59%	480,672 $77.7 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $9.51 Million - $10.9 Million	-70,877 Reduced 21.85%	253,534 $34 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $9 Million - $11.4 Million	-65,420 Reduced 16.78%	324,411 $49.7 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $6.9 Million - $8.56 Million	52,279 Added 15.49%	389,831 $63.2 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $438,314 - $554,594	4,080 Added 1.22%	337,552 $45.7 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $3.09 Million - $3.51 Million	29,045 Added 9.54%	333,472 $36 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $12.3 Million - $13.7 Million	-117,301 Reduced 27.81%	304,427 $34.3 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $29.4 Million - $32.4 Million	-287,672 Reduced 40.55%	421,728 $45.6 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $65.7 Million - $88.7 Million	-816,393 Reduced 53.51%	709,400 $76 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $18.8 Million - $22.1 Million	-219,350 Reduced 12.57%	1,525,793 $134 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $10.1 Million - $13.5 Million	-137,133 Reduced 7.29%	1,745,143 $171 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $73.4 Million - $111 Million	-1,137,749 Reduced 37.67%	1,882,276 $143 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $1.43 Million - $1.79 Million	-19,813 Reduced 0.65%	3,020,025 $267 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $27.4 Million - $32.9 Million	434,570 Added 16.68%	3,039,838 $230 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $108 Million - $137 Million	1,636,248 Added 168.86%	2,605,268 $189 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $64.7 Million - $76.2 Million	839,173 Added 646.28%	969,020 $78.1 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.99 Million - $2.45 Million	-25,553 Reduced 16.44%	129,847 $12 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.49 Million - $1.66 Million	-16,777 Reduced 9.74%	155,400 $14.7 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $80.4 Million - $95.2 Million	-895,883 Reduced 83.88%	172,177 $16 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $98.3 Million - $132 Million	1,068,060 New	1,068,060 $101 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account